Výsledky vyhľadávania - "Lindqvist, Anton"
-
1
Efficient protein production inspired by how spiders make silk
ISSN: 2041-1723, 2041-1723Vydavateľské údaje: London Nature Publishing Group UK 23.05.2017Vydané v Nature communications (23.05.2017)“…Membrane proteins are targets of most available pharmaceuticals, but they are difficult to produce recombinantly, like many other aggregation-prone proteins…”
Získať plný text
Journal Article -
2
Phase III, randomised, double-blind, placebo-controlled, multicentre trial to evaluate the efficacy and safety of rhGAD65 to preserve endogenous beta cell function in adolescents and adults with recently diagnosed type 1 diabetes, carrying the genetic HLA DR3-DQ2 haplotype: the DIAGNODE-3 study protocol
ISSN: 2044-6055, 2044-6055Vydavateľské údaje: London British Medical Journal Publishing Group 31.10.2022Vydané v BMJ OPEN (31.10.2022)“…IntroductionType 1 diabetes (T1D) is an autoimmune disease leading to the destruction of the insulin-producing beta cells resulting in insulin deficiency and…”
Získať plný text
Journal Article Publikácia -
3
Redosing with Intralymphatic GAD-Alum in the Treatment of Type 1 Diabetes: The DIAGNODE-B Pilot Trial
ISSN: 1422-0067, 1661-6596, 1422-0067Vydavateľské údaje: Switzerland MDPI AG 01.01.2025Vydané v International journal of molecular sciences (01.01.2025)“…Immunotherapies aimed at preserving residual beta cell function in type 1 diabetes have been successful, although the effect has been limited, or raised safety…”
Získať plný text
Journal Article -
4
Assisting the implementation of screening for type 1 diabetes by using artificial intelligence on publicly available data
ISSN: 0012-186X, 1432-0428, 1432-0428Vydavateľské údaje: Berlin/Heidelberg Springer Berlin Heidelberg 01.06.2024Vydané v Diabetologia (01.06.2024)“…The type 1 diabetes community is coalescing around the benefits and advantages of early screening for disease risk. To be accepted by healthcare providers,…”
Získať plný text
Journal Article -
5
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis
ISSN: 2213-8595, 2213-8595Vydavateľské údaje: England 01.12.2023Vydané v The lancet. Diabetes & endocrinology (01.12.2023)“…Metabolic outcomes in type 1 diabetes remain suboptimal. Disease modifying therapy to prevent β-cell loss presents an alternative treatment framework but the…”
Zistit podrobnosti o prístupe
Journal Article -
6
Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli
ISSN: 1460-2091, 1460-2091Vydavateľské údaje: England 01.09.2008Vydané v Journal of antimicrobial chemotherapy (01.09.2008)“…The biological fitness cost of antibiotic resistance is a key parameter in determining the rate of appearance and spread of antibiotic-resistant bacteria. We…”
Zistit podrobnosti o prístupe
Journal Article